HEATHER TAYLOR: Open Payments
NPI 1770884298 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 39 payments from 9 companies in 2025. Trend: 2023 $499 · 2024 $862 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $321 |
| ABBVIE INC. | 8 | $140 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| PFIZER INC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Amgen Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: Ozempic, QULIPTA, VRAYLAR, LEQVIO, PREVNAR 20, AIRSUPRA, FARXIGA, Kerendia.
Industry payments across FL — which companies pay providers there.
